General and Plastic Surgery Devices Panel
This article was originally published in The Gray Sheet
Premarket approval application for Lifecore Biomedical's Intergel absorbable adhesion barrier device is slated to be reviewed at Jan. 12 panel meeting from 10:30 a.m. to 5:00 p.m. at FDA's Corporate Building in Rockville, Maryland
You may also be interested in...
Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.
Krka’s bottom line continues to be stronger than usual, driven by a hike in sales and leaner cost base. Looking to 2021, however, management brought investors back down to earth.
The COVID-19 pandemic has triggered extraordinary levels of collaboration. But competition remains, and many newly created coalitions have yet to be stress tested.